Intensified insulin therapy plus antineuritic medication is more effective than antineuritics alone in painful diabetic neuropathy;La insulinoterapia intensificada más antineuríticos es superior a antineurítico puro en neuropatía diabética dolorosa

Revista Medica de Chile

Volumn 134, Issue 12, 2006, Pages 1507-1515

  Bastías A, M Juliana ^a   Toro C, Luis ^a   Olmos Coelho, Pablo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Diabetic neuropathies; Gabapentin; Hemoglobins; Insulin, long acting

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENERGIC RECEPTOR AFFECTING AGENT; AMINE; ANALGESIC AGENT; ANTIDIABETIC AGENT; CLOMIPRAMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; NORTRIPTYLINE;

ADULT; AGED; ARTICLE; DIABETIC NEUROPATHY; DRUG COMBINATION; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NEURALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; AMINES; ANALGESICS; CLOMIPRAMINE; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEURALGIA; NORTRIPTYLINE; RETROSPECTIVE STUDIES;

EID: 33846498543     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110: 628-38.
2. Oyibo SO, Prasad YDM, Jackson NJ, Jude EB, Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002; 19: 870-3.
3. Vinik A. Clinical Review: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 2005; 90: 4936-45.
4. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
5. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diab Res Clin Pract 1996; 28: 103-17.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type-2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
7. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001; 57: 505-9.
8. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J et al. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology 2004; 63: 865-73.
9. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes-A randomized placebo-controlled study. Acta Neurol Scand 2002; 106: 248-52.
10. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998; 280: 1831-6.
11. Porte D Jr, Schwartz MW. Diabetes complications: why is glucose potentially toxic? Science 1996; 272: 699-700.
12. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998; 47: 1155-7.
13. Misur I, Zarkovic K, Barada A, Batelja L, Milicevic Z, Turk Z. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol 2004; 41: 158-66.
14. Kalichman MW, Powell HC, Mizisin AP. Reactive, degenerative and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol 1998; 95: 47-56.